Hemochromatosis. More common than you think

Canadian Family Physician

Volumn 49, Issue JAN., 2003, Pages 36-43

  Borgaonkar, Mark Ram ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN;

ARTICLE; AWARENESS; CARDIOMYOPATHY; CAUCASIAN; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; GENERAL PRACTITIONER; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON DEPLETION; IRON OVERLOAD; IRON THERAPY; LABORATORY TEST; LIVER CIRRHOSIS; MEDICAL LITERATURE; MEDLINE; PHLEBOTOMY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; SYMPTOMATOLOGY; TREATMENT PLANNING;

ALGORITHMS; DIET; FEMALE; HEMOCHROMATOSIS; HUMANS; MALE; PHLEBOTOMY;

EID: 0037247905     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-8.
2. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
3. McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, et al. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619-24.
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
5. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists: hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
6. Bacon BR. Diagnosis and management of hemochromatosis. Gastroenterology 1997;113:995-9.
7. Adams PC, Chakrabarti S. Genotypic /phenotypic correlations in genetic hemochromatosis: evolution of diagnosis criteria. Gastroenterology 1998;114:319-23.
8. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
9. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999;116:193-207.
10. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Consensus statement: hereditary hemochromatosis. JAMA 1998;280:172-8.
11. Lush RB, Duggan PR, Xie Y, Borgaonkar MR. Biochemical abnormalities in patients with one or more C282Y or H63D mutations of the HFE gene for hereditary hemochromatosis [abstract]. Am J Gastroenterol 2001;96(9 Suppl):S129.
12. Burke W, Press N, McDonnell SM. Hemochromatosis genetics helps define a multifactorial disease. Clin Genet 1998;54:1-9.
13. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med 1998;129:946-53.
14. Adams PC. Hemochromatosis: new insights in pathogenesis and diagnosis following the discovery of the gene. Crit Rev Clin Lab Sci 1998;35:239-73.
15. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
16. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared to men. Ann Intern Med 1997;127:105-10.
17. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-6.
18. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-7.
19. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis Ann Intern Med 1998;129:925-31.
20. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med 1998;129:971-9.
21. McLaren CE, McLachlan GJ, Halliday JW, Webb SI, Leggett BA, Jazwinska EC, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9.
22. Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, et al. Harrison's principle of internal medicine. 12th ed. New York, NY: McGraw-Hill Inc; 1991. p. 1519-20.
23. Summers KM, Halliday JW, Powell LW, Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-5.
24. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
25. Brissot P, Moirand R, Guyader D, Loreal O, Turlin B, Deugnier Y. Hemochromatosis after the gene discovery: revisiting the diagnostic strategy. J Hepatol 1998;28:14-8.
26. Weterhall SF, Cogswell ME, Kowdley KV. Public health surveillance for hereditary hemochromatosis. Ann Intern Med 1998;129:980-6.
27. Adams PC, Valberg LS. Screening genotype to phenotyping. Am J Gastroenterol 1999;94:1593-600.
28. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Ann Intern Med 1998;129:932-9.
29. Bonford A, Williams R. Long term results of vensection therapy in idiopathic hemochromatosis. Q J Med 1976;180:611-23.
30. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
31. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
32. Rivers J, Garrahy P, Robinson W, Murphy A. Reversible cardiac dysfunction in hemochromatosis. Am Heart J 1987;113:216-7.
33. Lufkin EG, Baldus WP, Bergstrahl EJ, Kao PC. Influence of phelbotomy treatment of abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc 1987;62:473-9.
34. Schumacher Hr, Straka PC, Krikker MA, Dubley AT. The arthropathy of hemochromatosis. Recent studies. Ann N Y Acad Sci 1988;526:224-33.
35. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to medicare. Transplantation 1993;56:554-61.
36. Olsson KS, Vaisanen M, Konar J, Bruce A. The effect of the withdrawal of food iron fortification in Sweden as studied with phlebotomy in subjects with genetic hemochromatosis. Eur J Clin Nutr 1997;51:782-6.
37. Celada A, Rudolf H, Donath A. Effect of experimental chronic alcohol ingestion and folic acid deficiency on iron absorption. Blood 1979;54:906-15.
38. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DHG. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-9.
39. Nienhuis AW. Vitamin C and iron. N Engl J Med 1981;304:170-1.
40. Tuntawiroon M, Sritongkul N, Bruce M, Rossander-Hulten L, Pleehachinda R, Suwanik R, et al. Dose-dependent inhibitory effect of phenolic compounds in foods on nonheme-iron absorption in men. Am J Clin Nutr 1991;53:554-7.
41. Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic hemochromatosis. Gut 1998;43:699-704.
42. Tan L, Khan MK, Hawk JC. Use of blood therapeutically drawn from hemochromatosis patients. Transfusion 1999;39:1018-26.
43. Read EJ, Herron RM, Hughes DM. Effect of non-monetary incentives on safety of blood donations [abstract]. Transfusion 1993;33(Suppl 95):45S.
44. Levstik M, Adams PC. Eligibility and exclusion of hemochromatosis patients as voluntary blood donors. Can J Gastroenterol 1998;12:61-3.
45. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keefe EB, et al. Primary liver cancer and survival in hereditary hemochromatosis patients undergoing orthotopic liver transplantation. Liver Transplant Surg 1995;1:237-41.
46. Sherman M. Surveillance for hepatocellular carcinoma. Semin Oncol 2001;28:450-9.